Prot #NU 12S02: A Phase II Study of Tivozanib in Patients with Metastatic and Non-resectable Soft Tissue Sarcomas

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/14/13 → 2/14/19

Funding

  • AVEO Pharmaceuticals, Inc. (Prot #NU 12S02)